期刊文献+

纳米级磁性多柔比星脂质体的制备 被引量:1

Preparation and property of magnetic doxorubicin nanoliposomes
下载PDF
导出
摘要 目的制备纳米级磁性多柔比星脂质体(DOX-MLP)。方法用反相蒸发法制备纳米级DOX-MLP,以正交实验设计确定最佳制备工艺。电镜观察脂质体形态,zetapal粒度分析仪测量其粒径,紫外sephadex G-50法测定其包封率,磁测仪测量其磁响应性。结果DOX-MLP呈圆形或椭圆形,粒径为(293.4±20.6)nm,包封率为30.8%±3.27%,磁响应性(50.28±7.8)emu。结论用反相蒸发法制备的磁性多柔比星脂质体平均粒径小,磁响应性高,达到纳米级标准。 Objective To prepare magnetic doxorubicin (DOX) nanoliposomes. Methods Magnetic DOX liposomes (DOX-MLP) were prepared by the reverse-phase evaporation method,an optimal technique was chosen with orthogonal design, and its diameter distribution was observed under electronic microscope. Its encapsulation efficiency was detected by the sephadex column-ultraviolet method ,the magnetic properties of the DOX-MLP were measured with a magnetometer. Result The DOX-MLP were globular or elliptic, the average particle size was (293.4 + 20.6) nm, its encapsulation efficiency was 30.8% + 3.27%, and its average magnetic response was (50.28 + 7.8) emu. Conclusion The DOX-MLP prepared by thereverse-phase evaporation method have litter diameter and high magnetic response.
出处 《山东医药》 CAS 北大核心 2009年第46期18-19,共2页 Shandong Medical Journal
基金 国家"863"重点基金资助项目(2001AA218051)
关键词 磁性 纳米脂质体 反相蒸发法 包封率 磁响应性 magnetic nanolipsomes reverse phase evaporation encapsulation efficiency magnetic response
  • 相关文献

参考文献8

  • 1Saiyed ZM, Telang SD, Ramchand CN. Application of magnetic techniques in the field of drug discovery and biomedicine[ J]. Biomag Res Tech,2003,18,1 ( 1 ) : 2.
  • 2Rocha FM, Pinho SC ,Zollner RL, et al. Preparation and characterization of affinity magnetoliposomes useful for the detection of antiphospholipid antibodies[J]. J Magn Magn Mater,2001,225( 1 ) : 101-108.
  • 3常桂民,段芳龄,杨淑英,盛剑秋.脂质体阿霉素的制备及包封率测定方法的研究[J].中国医院药学杂志,1999,19(6):328-331. 被引量:25
  • 4Jain RK. Barriers to drug delivery in solid tumors [ J ]. Sci Am, 1994,271 ( 1 ) :58-65.
  • 5Eric M. Molecular basis of cancer [ M ]. New York : Man R Liss Inc,1985:55.
  • 6Panyam J,Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue [J]. Adv Drug Deliv Rev,2003, 55(3) :329-347.
  • 7Kubo T, Sugita T, Shimose S, et al. Targeted delivery of anticancer drugs with intravenously administered magnetic liposomes in osteosarcoma-bearing hamsters[J], Int J Oncol,2000,17(2) :309-315.
  • 8Babincova M, Manec PC, Altanerova V, et al. AC-magnetic field controlled drug release from magnetoliposomes : design of a method for site-specific chemotherapy [ J ]. Bioelectrochemistry, 2002,55 (1-2) :17-19.

二级参考文献4

共引文献24

同被引文献20

引证文献1

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部